Skip to main content
Top
Published in: Indian Journal of Surgery 4/2021

01-08-2021 | Pancreatic Cancer | Surgical Techniques and Innovations

Can the Falciform Ligament Be the Most Ergonomic Patch in Portal Vein Reconstruction?

Authors: Orhan Aras, İsmail Gömceli

Published in: Indian Journal of Surgery | Issue 4/2021

Login to get access

Abstract

The target in pancreatic cancer surgery is to achieve R0 resection margin. Portal vein resection and reconstruction may be required for a clear margin. This case series is an evaluation of pancreatic cancer patients who underwent portal vein resection during pancreatico-duodenectomy. From January 2012 to January 2020 pancreatico-duodenectomy was performed in 134 patients and all consecutively done surgeries have been included. Of these 9 subjects required portal vein resection (male = 6, female = 3). The mean age was 65 years. Primary suturing and repair of portal vein could be successfully done in 4/9, portal vein primary anastomosis achieved in 2/9, and in 3 of 9 patients the portal vein defect being larger was repaired and successfully closed using a patch prepared from the falciform ligament. The patch was sutured to the portal vein with a continuous 5/0 prolene stitch. None of the 3 patients with falciform patch had complications such as bleeding or stenosis after 5 months following surgery. This technique has been used so far in the repair of perforation of the stomach and duodenum, in the control of pancreatic fistula and most importantly in the repair of defects in the vena cava. This study suggests that locally and immediately available falciform ligament can be used as an autologous graft to patch portal vein defects and is a valuable technique.
Literature
1.
go back to reference Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH (2013) Recent progress in pancreatic cancer. CA Cancer J Clin 63(5):318–348CrossRef Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH (2013) Recent progress in pancreatic cancer. CA Cancer J Clin 63(5):318–348CrossRef
3.
go back to reference Callery MP, Chang KJ, Fishman EK, Talamonti MS, William Traverso L, Linehan DC (2009) Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16(7):1727–1733CrossRef Callery MP, Chang KJ, Fishman EK, Talamonti MS, William Traverso L, Linehan DC (2009) Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16(7):1727–1733CrossRef
4.
go back to reference Isaji S, Mizuno S, Windsor JA, Bassi C, Fernandez-Del Castillo C, Hackert T, Hayasaki A, Katz MHG, Kim SW, Kishiwada M, Kitagawa H, Michalski CW, Wolfgang CL (2018) International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology 18(1):2–11. https://doi.org/10.1016/j.pan.2017.11.011CrossRef Isaji S, Mizuno S, Windsor JA, Bassi C, Fernandez-Del Castillo C, Hackert T, Hayasaki A, Katz MHG, Kim SW, Kishiwada M, Kitagawa H, Michalski CW, Wolfgang CL (2018) International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology 18(1):2–11. https://​doi.​org/​10.​1016/​j.​pan.​2017.​11.​011CrossRef
5.
go back to reference Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, Bassi C, Dervenis C, Fernandez-Cruz L, Lacaine F, Buckels J, Deakin M, Adab FA, Sutton R, Imrie C, Ihse I, Tihanyi T, Olah A, Pedrazzoli S, Spooner D, Kerr DJ, Friess H, Büchler MW, European Study Group for Pancreatic Cancer (2001) Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758–768CrossRef Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, Bassi C, Dervenis C, Fernandez-Cruz L, Lacaine F, Buckels J, Deakin M, Adab FA, Sutton R, Imrie C, Ihse I, Tihanyi T, Olah A, Pedrazzoli S, Spooner D, Kerr DJ, Friess H, Büchler MW, European Study Group for Pancreatic Cancer (2001) Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758–768CrossRef
6.
go back to reference Illuminati G, Carboni F, Pacilè MA, Ceccanei G, Pizzardi G, Palumbo P, Vietri F (2013) Polytetrafluoroethylene versus autogenous vein for patch reconstruction of the portal/superior mesenteric vein during pancreatectomy. Am Surg 79(4):E151–E153CrossRef Illuminati G, Carboni F, Pacilè MA, Ceccanei G, Pizzardi G, Palumbo P, Vietri F (2013) Polytetrafluoroethylene versus autogenous vein for patch reconstruction of the portal/superior mesenteric vein during pancreatectomy. Am Surg 79(4):E151–E153CrossRef
7.
go back to reference Zhiying Y, Haidong T, Xiaolei L, Yongliang S, Shuang S, Liguo L, Li X, Atyah M (2017) The falciform ligament as a graft for portal-superior mesenteric vein reconstruction in pancreatectomy. J Surg Res 218:226–231CrossRef Zhiying Y, Haidong T, Xiaolei L, Yongliang S, Shuang S, Liguo L, Li X, Atyah M (2017) The falciform ligament as a graft for portal-superior mesenteric vein reconstruction in pancreatectomy. J Surg Res 218:226–231CrossRef
8.
go back to reference Etkin Y, Foley PJ, Wang GJ, Guzzo TJ, Roses RE, Fraker DL, Drebin JA, Jackson BM (2016) Successful venous repair and reconstruction for oncologic resections. J Vasc Surg Venous Lymphat Disord 4(1):57–63CrossRef Etkin Y, Foley PJ, Wang GJ, Guzzo TJ, Roses RE, Fraker DL, Drebin JA, Jackson BM (2016) Successful venous repair and reconstruction for oncologic resections. J Vasc Surg Venous Lymphat Disord 4(1):57–63CrossRef
10.
go back to reference Smoot RL, Christein JD, Farnell MB (2006) Durability of portal venous reconstruction following resection during pancreaticoduodenectomy. J Gastrointest Surg 10:1371–1375CrossRef Smoot RL, Christein JD, Farnell MB (2006) Durability of portal venous reconstruction following resection during pancreaticoduodenectomy. J Gastrointest Surg 10:1371–1375CrossRef
11.
go back to reference Chandrasegaram MD, Eslick GD, Lee W, Brooke-Smith ME, Padbury R, Worthley CS, Chen JW, Windsor JA (2014) Anticoagulation policy after venous resection with a pancreatectomy: a systematic review. HPB 16:691–698CrossRef Chandrasegaram MD, Eslick GD, Lee W, Brooke-Smith ME, Padbury R, Worthley CS, Chen JW, Windsor JA (2014) Anticoagulation policy after venous resection with a pancreatectomy: a systematic review. HPB 16:691–698CrossRef
12.
go back to reference Dokmak S, Aussilhou B, Sauvanet A, Nagarajan G, Farges O, Belghiti J (2015) Parietal peritoneum as an autologous substitute for venous reconstruction in hepatopancreatobiliary surgery. Ann Surg 262:366–371CrossRef Dokmak S, Aussilhou B, Sauvanet A, Nagarajan G, Farges O, Belghiti J (2015) Parietal peritoneum as an autologous substitute for venous reconstruction in hepatopancreatobiliary surgery. Ann Surg 262:366–371CrossRef
13.
go back to reference Christians KK, Lal A, Pappas S, Quebbeman E, Evans DB (2010) Portal vein resection. Surg Clin North Am 90:309–322CrossRef Christians KK, Lal A, Pappas S, Quebbeman E, Evans DB (2010) Portal vein resection. Surg Clin North Am 90:309–322CrossRef
14.
go back to reference Jara M, Malinowski M, Bahra M, Stockmannn M, Schulz A, Pratschke J, Puhl G (2015) Bovine pericardium for portal vein reconstruction in abdominal surgery: a surgical guide and first experiences in a single center. Dig Surg 32:135–141CrossRef Jara M, Malinowski M, Bahra M, Stockmannn M, Schulz A, Pratschke J, Puhl G (2015) Bovine pericardium for portal vein reconstruction in abdominal surgery: a surgical guide and first experiences in a single center. Dig Surg 32:135–141CrossRef
15.
go back to reference Chu CK, Farnell MB, Nguyen JH, Stauffer JA, Kooby DA, Sclabas GM, Sarmiento JM (2010) Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis. J Am Coll Surg 211:316–324CrossRef Chu CK, Farnell MB, Nguyen JH, Stauffer JA, Kooby DA, Sclabas GM, Sarmiento JM (2010) Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis. J Am Coll Surg 211:316–324CrossRef
16.
go back to reference Stauffer JA, DoughertyMK KGP, Nguyen JH (2009) Interposition graft with polytetrafluoroethylene for mesenteric and portal vein reconstruction after pancreaticoduodenectomy. Br J Surg 96:247–252CrossRef Stauffer JA, DoughertyMK KGP, Nguyen JH (2009) Interposition graft with polytetrafluoroethylene for mesenteric and portal vein reconstruction after pancreaticoduodenectomy. Br J Surg 96:247–252CrossRef
17.
go back to reference Krepline AN, Christians KK, Duelge K, Mahmoud A, Ritch P, George B, Erickson BA, Foley WD, Quebbeman EJ, Turaga KK, Johnston FM, Gamblin TC, Evans DB, Tsai S (2014) Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancer. J Gastrointest Surg 18(11):2016–2025CrossRef Krepline AN, Christians KK, Duelge K, Mahmoud A, Ritch P, George B, Erickson BA, Foley WD, Quebbeman EJ, Turaga KK, Johnston FM, Gamblin TC, Evans DB, Tsai S (2014) Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancer. J Gastrointest Surg 18(11):2016–2025CrossRef
Metadata
Title
Can the Falciform Ligament Be the Most Ergonomic Patch in Portal Vein Reconstruction?
Authors
Orhan Aras
İsmail Gömceli
Publication date
01-08-2021
Publisher
Springer India
Published in
Indian Journal of Surgery / Issue 4/2021
Print ISSN: 0972-2068
Electronic ISSN: 0973-9793
DOI
https://doi.org/10.1007/s12262-020-02532-0

Other articles of this Issue 4/2021

Indian Journal of Surgery 4/2021 Go to the issue